triamcinolone has been researched along with Macular Degeneration in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 28 (73.68) | 29.6817 |
| 2010's | 9 (23.68) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Spaide, RF | 1 |
| Cui, C; Lu, H | 1 |
| Amarakoon, S; Braaf, B; de Boer, JF; de Jong, JH; Gräfe, M; Missotten, T; van Velthoven, MEJ; Vermeer, KA; Yzer, S | 1 |
| Albert, R; Facskó, A; Fésüs, L; Kristóf, E; Moe, MC; Oláh, B; Petrovski, G; Szatmári-Tóth, M; Veréb, Z; Zahuczky, G | 1 |
| Aslankara, H; Kaynak, S; Koçak, N; Selım, A | 1 |
| Akhtar, S; Facskó, A; Fésüs, L; Kaarniranta, K; Kauppinen, A; Kristóf, E; Petrovski, G; Szatmári-Tóth, M; Veréb, Z | 1 |
| Augustin, AJ; Offermann, I | 1 |
| Leslie, T; Lois, N; McBain, V; Mendis, R | 1 |
| Dunavoelgyi, R; Geitzenauer, W; Michels, S; Prager, F; Pruente, C; Sacu, S; Schmidt-Erfurth, U; Weigert, G | 1 |
| Attaran, M; Dueck, N; Gamulescu, MA; Schubert, K; Spital, G; Stroux, A; Thormann, S; Wachtlin, J; Wiechens, B | 1 |
| Ho, CK; Tang, HH; Woo, CF; Yip, PP | 1 |
| Gerson, JD | 1 |
| Weber, U | 1 |
| Berényi, E; Berta, A; Facskó, A; Fésüs, L; Moe, MC; Petrovski, G; Vajas, A | 1 |
| Dib, E; Farah, ME; Furlani, BA; Melo, GB; Penha, FM; Rodrigues, EB | 1 |
| Ataka, S; Iwami, H; Kaida, M; Kohno, T; Miki, N; Shiraki, K; Yamamoto, M | 1 |
| Engelmann, K; Fauser, S; Joussen, AM; Kirchhof, B; Krohne, TU; Lappas, A | 1 |
| Comhaire-Poutchinian, Y; Duchateau, E; Galand, A; Rakic, JM; Zelinkova, M | 1 |
| Gao, H; Gao, R; Holz, ER; McPherson, AR; Mieler, WF; Qiao, X | 1 |
| Bhatt, U | 1 |
| Chan, CK; Chan, WM; Fan, DS; Lai, WW; Lam, DS; Lee, VY | 1 |
| Kaiser, PK | 1 |
| Chan, WM; Lai, TY; Lam, DS; Liu, DT; Tong, JP; Wong, AL | 1 |
| Kampik, A; Krieglstein, TR; Ulbig, M | 1 |
| Bearelly, S; Cooney, MJ; Fackler, TK; Fekrat, S; Reddy, S; Stinnett, S | 1 |
| Etter, J; Fekrat, S | 1 |
| Ahmadieh, H; Azarmina, M; Dehghan, MH; Karkhaneh, R; Lashay, A; Moradian, S; Riazi-Esfahani, M; Soheilian, M; Taei, R | 1 |
| He, YG; Kramar, M; Vu, L; Whitson, JT | 1 |
| Geitzenauer, W; Hahn, R; Michels, S; Sacu, S; Schmidt-Erfurth, U; Varga, A; Vécsei-Marlovits, P; Weigert, G | 1 |
| Bearelly, S; Cousins, SW; Espinosa-Heidmann, DG | 1 |
| Bunse, A; Frimpong-Boateng, A; Roider, J; Rüfer, F; Varde, MA | 1 |
| Geitzenauer, W; Michels, S; Prager, F; Sacu, S; Schmidt-Erfurth, U; Varga, A; Weigert, G | 1 |
| Hoerauf, H; Horn, W | 1 |
| Doggrell, SA | 1 |
| Ciulla, TA; Danis, RP; Pratt, L; Ranson, NT | 1 |
| Penfold, PL | 1 |
6 review(s) available for triamcinolone and Macular Degeneration
| Article | Year |
|---|---|
Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis.
Topics: Aged; Angiogenesis Inhibitors; China; Female; Glucocorticoids; Humans; Hyperthermia, Induced; Intravitreal Injections; Macular Degeneration; Male; Ranibizumab; Recombinant Fusion Proteins; Retina; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
[Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches].
Topics: Alprostadil; Angiogenesis Inhibitors; Antioxidants; Choroidal Neovascularization; Clinical Trials as Topic; Combined Modality Therapy; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Triamcinolone; Vascular Endothelial Growth Factor A | 2008 |
Toxicological considerations for intravitreal drugs.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials as Topic; Humans; Intravitreal Injections; Macular Degeneration; Macular Edema; Ranibizumab; Triamcinolone; Vascular Endothelial Growth Factor A | 2011 |
[Pathogenesis of choroidal neovascularization. Old concepts, new questions].
Topics: Age Factors; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Cells, Cultured; Choroidal Neovascularization; Choroiditis; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Disease Models, Animal; Endothelial Growth Factors; Eye Injuries; Haplorhini; Humans; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Laser Therapy; Lymphokines; Macula Lutea; Macular Degeneration; Mice; Mice, Transgenic; Myopia; Photochemotherapy; Pigment Epithelium of Eye; Rats; Retinal Neovascularization; Risk Factors; Triamcinolone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effect.
Topics: Choroidal Neovascularization; Drug Therapy, Combination; Glucocorticoids; Humans; Macular Degeneration; Photosensitizing Agents; Porphyrins; Triamcinolone; Verteporfin; Visual Acuity | 2005 |
Triamcinolone: new and old indications.
Topics: Administration, Intranasal; Adult; Aerosols; Androstadienes; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Astemizole; Asthma; Child; Clinical Trials as Topic; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Fluticasone; Humans; Injections, Intramuscular; Loratadine; Lung Diseases, Obstructive; Macular Degeneration; Molecular Structure; Nasal Mucosa; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Structure-Activity Relationship; Triamcinolone | 2001 |
9 trial(s) available for triamcinolone and Macular Degeneration
| Article | Year |
|---|---|
Triamcinolone regulated apopto-phagocytic gene expression patterns in the clearance of dying retinal pigment epithelial cells. A key role of Mertk in the enhanced phagocytosis.
Topics: Anoikis; Anti-Inflammatory Agents; Antibodies, Neutralizing; c-Mer Tyrosine Kinase; Cell Line; Epithelial Cells; Eye Proteins; Female; Gene Expression Regulation, Enzymologic; Gene Silencing; Humans; Macrophages; Macular Degeneration; Male; Phagocytosis; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Retinal Pigment Epithelium; Triamcinolone | 2015 |
Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Triamcinolone; Visual Acuity | 2009 |
[ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Combined Modality Therapy; Exudates and Transudates; Female; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Treatment Outcome; Triamcinolone; Vitreous Body | 2009 |
Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract Extraction; China; Endothelium, Corneal; Female; Follow-Up Studies; Humans; Injections; Intraocular Pressure; Intraoperative Period; Macular Degeneration; Macular Edema; Male; Middle Aged; Triamcinolone; Vitreous Body | 2005 |
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Disease Progression; Female; Glucocorticoids; Humans; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Treatment Outcome; Triamcinolone; Verteporfin; Vision Disorders; Visual Acuity | 2006 |
Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2007 |
[Intravitreal bevacizumab versus verteporfin and intravitreal triamcinolone acetonide in patients with neovascular age-related macula degeneration].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Humans; Macular Degeneration; Photosensitizing Agents; Porphyrins; Retinal Neovascularization; Treatment Outcome; Triamcinolone; Verteporfin; Vision Disorders | 2007 |
[Intravitreal administration of triamcinolone and bevacizumab for pigment epithelial detachment in conjunction with AMD].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Female; Humans; Injections; Macular Degeneration; Male; Retinal Detachment; Retrospective Studies; Treatment Outcome; Triamcinolone; Vitreous Body | 2008 |
Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2008 |
23 other study(ies) available for triamcinolone and Macular Degeneration
| Article | Year |
|---|---|
Treatment of Sorsby fundus dystrophy with anti-tumor necrosis factor-alpha medication.
Topics: Adalimumab; Adult; Angiogenesis Inhibitors; Bevacizumab; Female; Fluorescein Angiography; Humans; Intravitreal Injections; Macular Degeneration; Necrosis; Retinal Dystrophies; Tissue Inhibitor of Metalloproteinase-3; Tomography, Optical Coherence; Triamcinolone; Tumor Necrosis Factor-alpha | 2022 |
Treatment Effects in Retinal Angiomatous Proliferation Imaged with OCT Angiography.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Receptors, Vascular Endothelial Growth Factor; Retina; Retinal Neovascularization; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone; Visual Acuity | 2019 |
Comparative study of photodynamic therapy monotherapy versus triple management in age-related macular degeneration.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Combined Modality Therapy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Male; Photochemotherapy; Treatment Outcome; Triamcinolone; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Clearance of autophagy-associated dying retinal pigment epithelial cells - a possible source for inflammation in age-related macular degeneration.
Topics: Adenine; Autophagy; Biomarkers; Cell Line; Chloroquine; Coculture Techniques; Culture Media, Serum-Free; Gene Expression; Genes, Reporter; Green Fluorescent Proteins; Humans; Hydrogen Peroxide; Interleukin-6; Interleukin-8; Macrophages; Macular Degeneration; Microtubule-Associated Proteins; Models, Biological; Oxidative Stress; Phagocytosis; Primary Cell Culture; Retinal Pigment Epithelium; Triamcinolone | 2016 |
Combined therapy for retinal angiomatous proliferation with intravitreal triamcinolone and argon laser photocoagulation.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Humans; Laser Coagulation; Macular Degeneration; Male; Retinal Neovascularization; Retrospective Studies; Triamcinolone | 2008 |
Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2009 |
Costs of treatment for age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Drug Costs; Glucocorticoids; Humans; Macular Degeneration; Photochemotherapy; Treatment Outcome; Triamcinolone; United States; Vascular Endothelial Growth Factor A; Visual Acuity | 2009 |
[Exsudative AMD: Regression analysis of transpupillary thermotherapy with and without intravitreal injection of triamcinolone, bevacizumab and ranibizumab].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Female; Humans; Hyperthermia, Induced; Intravitreal Injections; Macular Degeneration; Male; Ranibizumab; Retrospective Studies; Triamcinolone; Visual Fields | 2010 |
Clearance of dying ARPE-19 cells by professional and nonprofessional phagocytes in vitro- implications for age-related macular degeneration (AMD).
Topics: Annexin A5; Anoikis; Cell Survival; Cells, Cultured; Dose-Response Relationship, Radiation; Flow Cytometry; Humans; Macrophages; Macular Degeneration; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Models, Biological; Phagocytosis; Phosphatidylserines; Retinal Pigment Epithelium; Time Factors; Triamcinolone | 2011 |
Progression of cataracts following photodynamic therapy combined with intravitreous triamcinolone injection in cases of age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Cataract; Cataract Extraction; Disease Progression; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone; Visual Acuity | 2011 |
[Treatment of Graves macular edema with intravitreal injection of corticosteroids].
Topics: Adult; Aged; Aged, 80 and over; Follow-Up Studies; Glucocorticoids; Graves Disease; Humans; Injections; Macular Degeneration; Male; Middle Aged; Recurrence; Treatment Outcome; Triamcinolone; Visual Acuity | 2003 |
Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina.
Topics: Angiogenesis Inhibitors; Animals; Blotting, Northern; Choroid; Image Processing, Computer-Assisted; In Situ Hybridization; Injections; Macular Degeneration; Rats; Rats, Sprague-Dawley; Retina; RNA, Messenger; Triamcinolone; Vascular Endothelial Growth Factor A; Vitreous Body | 2004 |
Are we overlooking the side effects of the drugs in our zeal to conquer ARMD?
Topics: Cataract; Glucocorticoids; Humans; Intraocular Pressure; Macular Degeneration; Triamcinolone | 2004 |
[Comments on current therapeutic possibilities for neovascular age-related macula degeneration].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Germany; Glucocorticoids; Humans; Laser Coagulation; Macular Degeneration; Photochemotherapy; Porphyrins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnadienediols; Ranibizumab; Triamcinolone; Verteporfin | 2006 |
Macular degeneration. Advances in treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Glucocorticoids; Humans; Light Coagulation; Macular Degeneration; Photochemotherapy; Pregnadienediols; Ranibizumab; Triamcinolone | 2006 |
Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Injections; Laser Coagulation; Macular Degeneration; Male; Middle Aged; Prospective Studies; Reoperation; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone; Visual Acuity; Vitreous Body | 2006 |
Retrospective review of eyes with neovascular age-related macular degeneration treated with photodynamic therapy with verteporfin and intravitreal triamcinolone.
Topics: Age Factors; Aged; Choroidal Neovascularization; Female; Humans; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Treatment Outcome; Triamcinolone; Verteporfin | 2006 |
Photodynamic therapy and intravitreal triamcinolone for extrafoveal choroidal neovascularization in neovascular age-related macular degeneration.
Topics: Aged; Choroidal Neovascularization; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Treatment Outcome; Triamcinolone; Visual Acuity; Vitreous Body | 2006 |
The effect of intravitreal triamcinolone on intraocular pressure.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Diabetic Retinopathy; Drug Administration Routes; Drug Administration Schedule; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Middle Aged; Retrospective Studies; Risk Factors; Triamcinolone | 2007 |
The role of dynamic indocyanine green angiography in the diagnosis and treatment of retinal angiomatous proliferation.
Topics: Aged; Angiomatosis; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Laser Coagulation; Macular Degeneration; Male; Photochemotherapy; Recurrence; Retinal Neovascularization; Salvage Therapy; Tomography, Optical Coherence; Treatment Failure; Treatment Outcome; Triamcinolone | 2008 |
[Intravitreal injections during anticoagulant treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Aspirin; Bevacizumab; Choroidal Neovascularization; Clopidogrel; Conjunctival Diseases; Humans; Injections; Intracranial Hemorrhages; Macular Degeneration; Phenprocoumon; Platelet Aggregation Inhibitors; Prospective Studies; Ranibizumab; Risk Factors; Ticlopidine; Triamcinolone; Vitreous Body; Vitreous Hemorrhage | 2008 |
Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.
Topics: Anti-Inflammatory Agents; Choroidal Neovascularization; Humans; Laser Coagulation; Macular Degeneration; Recurrence; Triamcinolone | 2002 |
Intravitreal triamcinolone in recurrence of choroidal neovascularisation.
Topics: Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Choroidal Neovascularization; Humans; Macular Degeneration; Recurrence; Triamcinolone | 2002 |